Response of dystrophic calcification to intravenous immunoglobulin.
Schanz
Stefan
S
University of Tuebingen, Liebermeisterstrasse 25, Tuebingen 72076, Germany. Stefan.schanz@med.uni-tuebingen.de
Ulmer
Anja
A
Fierlbeck
Gerhard
G
D017675:CREST Syndrome / Q000150:complications; D002114:Calcinosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004487:Edema / Q000209:etiology / Q000473:pathology; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007249:Inflammation / Q000209:etiology / Q000473:pathology; D008875:Middle Aged; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous